• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148

Introduction to 4-Phenyl-2-(p-tolyl)thiazole (CAS No. 2227-61-4)

4-Phenyl-2-(p-tolyl)thiazole, identified by the chemical abstracts service number 2227-61-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential biological activities. This compound belongs to the thiazole class, which is well-documented for its broad spectrum of pharmacological effects, including antimicrobial, anti-inflammatory, and anticancer properties. The presence of both phenyl and p-tolyl substituents in its molecular structure enhances its chemical reactivity and interaction with biological targets, making it a promising candidate for further exploration in drug discovery.

The molecular structure of 4-Phenyl-2-(p-tolyl)thiazole consists of a five-membered ring containing sulfur and nitrogen atoms, with phenyl and p-tolyl groups attached at the 4th and 2nd positions, respectively. This arrangement contributes to its stability and flexibility, allowing it to adopt various conformations that may facilitate binding to biological macromolecules. The compound's solubility profile in common organic solvents such as ethanol, dimethyl sulfoxide (DMSO), and methanol also makes it amenable to various experimental techniques used in high-throughput screening and structural biology studies.

In recent years, there has been a surge in research focused on thiazole derivatives due to their demonstrated efficacy in modulating cellular pathways associated with diseases. Specifically, 4-Phenyl-2-(p-tolyl)thiazole has been investigated for its potential role in inhibiting enzymes that are overexpressed in cancer cells. For instance, studies have shown that this compound can interact with poly(ADP-ribose) polymerase (PARP) enzymes, which are implicated in DNA repair mechanisms and have been targeted in the treatment of certain cancers. The phenyl and p-tolyl groups may enhance binding affinity by forming hydrophobic interactions and π-stacking with the enzyme's active site.

Moreover, the thiazole core of 4-Phenyl-2-(p-tolyl)thiazole has been linked to anti-inflammatory properties through its ability to modulate cytokine production and inhibit inflammatory signaling pathways. Research has indicated that this compound may suppress the release of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), thereby reducing inflammation. These findings are particularly relevant given the increasing recognition of chronic inflammation as a contributing factor in various metabolic disorders and autoimmune diseases.

Another area of interest has been the antimicrobial activity of 4-Phenyl-2-(p-tolyl)thiazole. Preliminary studies have demonstrated its effectiveness against a range of bacterial strains, including those resistant to conventional antibiotics. The sulfur atom in the thiazole ring is believed to play a crucial role in disrupting bacterial cell wall synthesis or interfering with essential metabolic processes. This makes 4-Phenyl-2-(p-tolyl)thiazole a valuable candidate for developing novel antimicrobial agents to combat rising rates of antibiotic resistance.

The synthesis of 4-Phenyl-2-(p-tolyl)thiazole involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriate precursors under controlled conditions, followed by functional group modifications to introduce the phenyl and p-tolyl substituents. Advances in synthetic methodologies have enabled more efficient production processes, making it feasible to conduct large-scale studies on this compound's biological effects.

In conclusion, 4-Phenyl-2-(p-tolyl)thiazole (CAS No. 2227-61-4) represents a structurally intriguing molecule with significant potential in pharmaceutical applications. Its unique combination of substituents enhances its interaction with biological targets, while its solubility profile facilitates experimental investigations. Ongoing research continues to uncover new therapeutic possibilities for this compound, positioning it as a key player in the development of next-generation drugs targeting cancer, inflammation, and infections.

• 1826-16-0(2-Methyl-4-phenylthiazole)
• 66047-73-2(2-methyl-4-(4-methylphenyl)-1,3-thiazole)
• 1826-14-8(Thiazole, 2,4-diphenyl-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)